Drospirenone/Ethinyl Estradiol/Levomefolate Calcium

屈螺酮/炔雌醇/左甲柳叶酸钙

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug NameDrospirenone/Ethinyl Estradiol/Levomefolate Calcium
Drug Alias NameDrospirenone/Ethinyl Estradiol/Calcium Folate屈螺酮/炔雌醇/左旋甲柳叶酸钙Drospirenone/Ethinyl Estradiol/Levomefolate CalciumBEYAZ
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonistsAndrogen Receptor antagonistsMineralocorticoid receptor antagonists +[4] 
TargetsAndrogen ReceptorMineralocorticoid receptorProgesterone receptor +[4] 
Therapy Area/IndicationsContraceptionPremenstrual Dysphoric DisorderFolic Acid Deficiency +[4] 
Global Approved IndicationsContraceptionPremenstrual Dysphoric DisorderFolic Acid Deficiency +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2010/09/24
Country/TerritoryUnited States
CombinationsYes DrospirenoneEthinyl EstradiolLevomefolate calcium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesBayer HealthcareBayer Healthcare Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsContraceptionPremenstrual Dysphoric DisorderFolic Acid Deficiency +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeG03CA
Related LinksN/A